Authors:
Wang, JJ
Sandefur, S
Spearman, P
Chiou, CT
Chiang, PH
Ratner, L
Citation: Jj. Wang et al., Tracking the assembly pathway of human immunodeficiency virus type 1 Gag deletion mutants by immunogold labeling, APPL IMMUNO, 9(4), 2001, pp. 371-379
Citation: R. Suara et al., Mycobacteria fortuitum central venous catheter-related bacteremia in an infant with renal sarcoma, PED HEM ONC, 18(5), 2001, pp. 363-365
Authors:
Spearman, P
Fiscus, SA
Smith, RM
Shepard, R
Johnson, B
Nicotera, J
Harris, VL
Clough, LA
McKinsey, J
Haass, DW
Citation: P. Spearman et al., Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid, J CLIN MICR, 39(4), 2001, pp. 1612-1614
Authors:
Haas, DW
Clough, LA
Johnson, BW
Harris, VL
Spearman, P
Wilkinson, GR
Fletcher, CV
Fiscus, S
Raffanti, S
Donlon, R
McKinsey, J
Nicotera, J
Schmidt, D
Shoup, RE
Kates, RE
Lloyd, RM
Larder, B
Citation: Dw. Haas et al., Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma, AIDS RES H, 16(15), 2000, pp. 1491-1502
Authors:
Tang, YW
Huong, JTJ
Lloyd, RM
Spearman, P
Haas, DW
Citation: Yw. Tang et al., Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma, J CLIN MICR, 38(12), 2000, pp. 4637-4639
Citation: A. Deora et al., The N-terminal matrix domain of HIV-1 gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism, VIROLOGY, 269(2), 2000, pp. 305-312
Authors:
Sandefur, S
Smith, RM
Varthakavi, V
Spearman, P
Citation: S. Sandefur et al., Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag), J VIROLOGY, 74(16), 2000, pp. 7238-7249
Authors:
Haas, DW
Stone, J
Clough, LA
Johnson, B
Spearman, P
Harris, VL
Nicotera, J
Johnson, RH
Raffanti, S
Zhong, L
Bergqwist, P
Chamberlin, S
Hoagland, V
Ju, WD
Citation: Dw. Haas et al., Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection, CLIN PHARM, 68(4), 2000, pp. 367-374
Authors:
Gicheru, MM
Otsyula, M
Spearman, P
Graham, BS
Miller, CJ
Robinson, HL
Haigwood, NL
Montefiori, DC
Citation: Mm. Gicheru et al., Neutralizing antibody responses in Africa green monkeys naturally infectedwith simian immunodeficiency virus (SIVagm), J MED PRIM, 28(3), 1999, pp. 97-104
Citation: V. Varthakavi et al., Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus, J VIROLOGY, 73(12), 1999, pp. 10329-10338
Citation: Zy. Fang et al., Efficient human immunodeficiency virus (HIV)-1 Gag-Env pseudovirion formation elicited from mammalian cells by a canarypox HIV vaccine candidate, J INFEC DIS, 180(4), 1999, pp. 1122-1132